Alumis' TYK2 drug succeeds in key psoriasis studies, will seek FDA approval
Alumis' TYK2 drug succeeds in key psoriasis studies, will seek FDA approval
本文は利用できません。元の情報源をご確認ください。
Alumis' TYK2 drug succeeds in key psoriasis studies, will seek FDA approval